Market Report -- In Play (ZGEN)

Market Report -- In Play (ZGEN)
MSN Money - 59 minutes ago
ZymoGenetics and Bristol-Myers Squibb present final Ph. 1b results for PEG-Interferon lambda in hepatitis C Co and Bristol-Myers Squibb (BMY) present final results from a Phase 1b clinical trial ...
BMY and ZGen present Phase 1B results for PEG-Interferon lambda in HCV patients - News-Medical.net